Literature DB >> 3612987

Reactor accidents. Public health strategies and their medical implications.

D V Becker.   

Abstract

In a reactor accident with release of radioactivity, the major potential public health risks are likely to result from radioiodines, particularly iodine 131, which can be readily volatilized and dispersed. They are rapidly absorbed and concentrated by the thyroid, which could result in substantial thyroidal radiation. Although some forms of radiation can cause thyroid cancer in humans, 131I has not been shown to do so, and 40 years of safe experience with this radionuclide in routine clinical thyroid testing and treatment has been reassuring. Nevertheless, since 131I has been shown to cause thyroid neoplasms in animals, efforts to minimize unwarranted exposure seem advisable. Potassium iodide, administered at an appropriate time, will effectively block thyroid uptake, but it has potential toxicity and may be difficult to distribute effectively and safely on a large scale in an emergency. Evaluation of the risks and benefits of potassium iodide use is essential to establishing sound public health policy but awaits additional scientific information.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3612987     DOI: 10.1001/jama.258.5.649

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  3 in total

1.  Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations.

Authors:  D Casara; D Rubello; G Saladini; A Piotto; M R Pelizzo; M E Girelli; B Busnardo
Journal:  Eur J Nucl Med       Date:  1993-03

Review 2.  Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion.

Authors:  Li Jing; Qiang Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

3.  Cancer risks in thyroid cancer patients.

Authors:  P Hall; L E Holm; G Lundell; G Bjelkengren; L G Larsson; S Lindberg; J Tennvall; H Wicklund; J D Boice
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.